The National Alliance of State and Territorial AIDS Directors (NASTAD) represents the nation's chief state health agency staff who have programmatic responsibility for administering HIV/AIDS healthcare, prevention, education, and supportive service programs funded by state and federal governments. NASTAD is dedicated to reducing the incidence of HIV/AIDS infection in the U.S. and its territories, providing comprehensive, compassionate, and high-quality care to all persons living with HIV/AIDS, and ensuring responsible public policies. NASTAD provides national leadership to achieve these goals, and to educate about and advocate for the necessary federal funding to achieve them, as well as to promote communication between state and local health departments and HIV/AIDS care and treatment programs. NASTAD supports and encourages the use of applied scientific knowledge and input from affected communities to guide the development of effective policies and programs.
AIDS directors in all 50 U.S. states, the District of Columbia , Puerto Rico, the U.S. Virgin Islands, and the U.S. Pacific Islands are represented by NASTAD, with an office in Washington, D.C. Programs administered by NASTAD members serve every population affected by and infected with HIV/AIDS. As such, NASTAD members offer considerable expertise in identifying community needs and responding to the challenges of the HIV/AIDS epidemic nationwide and throughout the world.
NASTAD strengthens state and territory-based leadership, expertise, and advocacy and brings them to bear in reducing the incidence of HIV and viral hepatitis infections and on providing care and support to all who live with HIV/AIDS and viral hepatitis. NASTAD's vision is a world free of HIV/AIDS and viral hepatitis.
444 N. Capitol Street, NW, Suite 339
Washington, D.C. 20001
Categories Covered:Meeting the Costs of HIV Care, HIV Advocacy and Activism, HIV Stigma and Discrimination, Tools and Tips for HIV Advocacy, HIV Policy and Advocacy, HIV-Related Policy Issues, HIV Prevention and Transmission, HIV Prevention Methods, Adverse Events, Comorbidities, and HIV, HIV Prevention for People With HIV, Women, Gay Men, Latinx People, Non-HIV Sexually Transmitted Infections, Raltegravir (Isentress), PrEP (HIV Pre-Exposure Prophylaxis), HIV Treatment Strategies, Financial Issues, Living Well With HIV, African-Americans, HIV Care and Services Outside the US, HIV Treatment and Medical Care, Mental Health, Substance Use and Harm Reduction for HIV
"The number of people newly diagnosed with HIV in New York state has fallen to historic lows, proving that efforts to end the epidemic are making a significant impact," Johanne Morne writes.
Talking about STDs to your sexual partners and your healthcare provider is critical to maintaining good sexual health. Here are suggestions for how to make these conversations a little less awkward and a lot more empowering.
Annie Coriolan wants to educate and encourage others to take the necessary steps in preventing and treating HIV.
NASTAD joins global public health experts in raising awareness about the latest science of HIV transmission risk to end the dual epidemics of HIV and HIV-related stigma and reduce new HIV infections.
"When messaging labels everyday behaviors and realities for black MSM as 'risk factors' for HIV, it implies that HIV diagnosis is an inevitability for black MSM," Marcel Byrd writes.
At the United States Conference on AIDS (USCA) this week, National Alliance of State & Territorial AIDS Directors announced its commitment to communicating one of the most ground-breaking developments in the last two decades of the epidemic: People l...
NASTAD has launched the "Ready to End the HIV and Viral Hepatitis Epidemics" Chair's Challenge that calls on U.S. health departments to accelerate the end of HIV and viral hepatitis in the U.S.
Breaking down siloes, revolutionizing public health services and reducing stigma are just a few ways we can realize a future free of new HIV infections, according to NASTAD.
"Prioritization is usually determined based on a patient's level of cirrhosis, or liver scarring," explains Maribel Rodriguez-Torres, M.D., a leader in hepatitis C research and treatment in Puerto Rico.
"Stigma delayed and hindered every part of the early response to HIV," writes Andrew Gans. "Communities came together to respond to HIV when public health and other systems wouldn't." While things have changed enormously in the last thirty years, Gan...